Form 4: Erasca's Chief Medical Officer, Shannon Morris, Reports Stock Option Grant

Chief Medical Officer of Erasca, Shannon Morris, reports the acquisition of stock options.

Summary

• On February 5, 2025, Shannon Morris, Chief Medical Officer of Erasca, Inc., filed a Form 4.
• The filing reports the grant of stock options to Morris on February 3, 2025.
• Morris acquired options to purchase 780,000 shares of Erasca's common stock at an exercise price of $1.76 per share.
• The options vest monthly, with 1/48th of the shares vesting each month starting February 1, 2025, contingent upon continuous service.
• The options expire on February 2, 2035.
• Following the transaction, Morris directly owns derivative securities for 780,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice, indicating confidence in the company's future performance.

Positives

• The grant of stock options to the Chief Medical Officer aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Biogen also use stock options to incentivize their executives.
• The size of the grant (780,000 shares) would need to be compared to similar companies based on market capitalization and executive role to determine if it is within industry norms.

Stakeholder Impact

• The stock option grant aligns the Chief Medical Officer's interests with those of the shareholders, potentially leading to increased focus on long-term value creation.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, stock options, Erasca, Shannon Morris, Chief Medical Officer, beneficial ownership, securities